Navigation Links
Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
Date:10/12/2008

y engaged in discovering and developing novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry providing Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability for non-invasive delivery of siRNA to target tissues including the eye, ear, kidney, lung, spinal cord and brain.

PF-4523655 (RTP801i-14), currently in Phase II clinical trials, is a synthetic, chemically modified, siRNA molecule to inhibit the expression of the gene RTP801 discovered by Quark through the gene discovery platform BiFAR. PF-4523655 is licensed to Pfizer. In addition, Quark's current clinical pipeline includes AKIi-5, developed by Quark for the prevention of acute kidney injury (AKI) following major cardiac surgery, currently in Phase I/IIa clinical trials via systemic delivery and DGFi, about to start phase I/II for prevention of delayed graft function in kidney transplantation. Based on publicly available information, Quark believes AKIi-5 was the first siRNA administered systemically in a human clinical study.

In addition, Quark has a broad pipeline of siRNA drug candidates based on novel structures developed internally. The Company expects to utilize the structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at http://www.quarkpharma.com

Quark Pharmaceuticals, Inc.

Juliana Friedman

+972 89 30 5111

jfriedman@quarkpharma.com

The Ruth Group (investors / media)

Sara Ephraim / Janine McCargo

(646) 536-7004 / 7033


SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015  Leaf ... burden that pressure ulcers place on the healthcare ... a leading threat to modern quality healthcare. Research ... Services, Agency for Healthcare Research and Quality shows ... more than $11 billion a year. The condition ...
(Date:7/28/2015)... 2015  Today, Sekisui Diagnostics announces the launch of ... instrument, with a broad menu of high quality SEKURE ... physicians, office or hospital laboratory. The ... with ISE, 72 patient sample on-board capability, minimizes the ... (+3 ISE) to meet the testing needs of small-to-moderate ...
(Date:7/28/2015)... 2015 Voalte, the leader in healthcare ... purpose-built wireless communications, today announced that Bay Area ... acute-care facility in Webster, Texas ... solution on Spectralink PIVOT™ purpose-built smartphones for caregiver ... a member of its AIMS Partner Program last ...
Breaking Medicine Technology:Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3
... STOCKHOLM, December 21 Karolinska Development has,successfully completed ... will secure Karolinska Development,s continued active investment,strategy in its portfolio ... this share issue shows confidence in the,strength of our business ... strategy. I am also pleased that we have attracted 450 ...
... Dec. 18 Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a ... products primarily for the respiratory and related markets, today announced ... ET on Thursday, January 7, 2010, to discuss its financial ... release outlining its financial guidance for 2010 prior to the ...
Cached Medicine Technology:Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR) 2Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 2Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 3
(Date:7/28/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... technological invention. It is a wearable personal tracking device that can communicate over ... high of $211.3 billion in 2014," says Scott Cooper, CEO and Creative Director ...
(Date:7/28/2015)... ... 2015 , ... Morristown Medical Center, part of Atlantic Health System, today announced ... hospitals in the nation, to implant the newly approved CoreValve® Evolut® R System from ... in good condition. , The CoreValve® Evolut® R System was approved by the U.S. ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Barack Obama’s visit to Ethiopia to learn more about the impact of U.S. ... . This initiative focuses on accelerating agricultural development as an engine of broad-based ...
(Date:7/28/2015)... ... 2015 , ... Women in Technology (WIT), the premier organization contributing to the ... has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the organization’s ... this organization that empowers women to thrive and excel in the technology field. In ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
Breaking Medicine News(10 mins):Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... severe bleeding and considerable transfusion requirements. There are several ... remain a major cause. , This study, performed by ... be published in the March 7, 2008 issue of ... protease inhibitor, is used increasingly often in surgeries during ...
... The article published in volume 14 issue 6 ... patient who presented to Dr Cosimo Sperti of ... an exploratory laparotomy performed in another hospital for ... the portal vein. Total pancreatectomy together with resection ...
... inVentiv Clinical,Solutions, LLC (inVentiv Clinical), a division of ... establish operations in Latin,America, a growing region for ... Sao Paulo, Brazil, with the plan to expand ... American operations,will be led by Ana Paula Ruenis, ...
... 13 Cardinal Health, a,global provider of ... and,productivity of health care, today announced the ... group president of its Healthcare Supply,Chain Services ... 45, will be responsible for Cardinal Health,s,largest ...
... fewer new cases over a decade , , THURSDAY, March 13 (HealthDay ... seems to reduce the risk of developing asthma among older women. ... , essentially mirrors a similar study in which men taking aspirin ... warned that the research was still not enough to recommend ...
... March 13 Medivation, Inc.,(Nasdaq: MDVN ) today ... will present at Cowen and Company,s 28th Annual Health,Care ... Time at The,Boston Marriott Copley Place in Boston., ... its clinical,development programs for Dimebon(TM) for Alzheimer,s and Huntington,s,diseases ...
Cached Medicine News:Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 2Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 3Health News:Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment 2Health News:Aspirin Reduces Asthma Risk Among Older Women 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
... cutting speeds (guillotine movements) are possible. Cutting ... off, thus minimizing tissue trauma. One can ... both can be combined together. There are ... bi-manual techniques. Lightweight autoclavable hand-pieces with single ...
... For Anterior and Posterior segment surgeries ... using Ventury or Peristaltic Linear Aspiration. ... for specific cutting action. Easy to ... movement. Cutting speed-variable from 1- 600 ...
Medicine Products: